| |
| |
NeuroResearch Clinics, Inc. |
| |
AMA Category 1
Continuing Medical Education |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
Homer,
Alaska Marina Photo By: Marty Hinz, MD |
| |
 |
|
Contact us or find
a caregiver using this approach. |
| |
| |
|
REUPTAKE INHIBITOR |
|
depression, anxiety, attention deficit, etc. |
|
DRUG HOME PAGE |
|
By: Marty Hinz, MD |
|
President Clinical Research |
|
NeuroResearch Clinics, Inc. |
|
|
|
If you just
entered this web site, landing on this page, you have landed on the
NeuroResearch Clinics discussion of prescription drugs in treatment
of depression web page. NeuroResearch Clinics is a neurotransmitter medical research project. The research work of
NeuroResearch Clinics is
currently being published in a series of papers by the University of
Minnesota Medical School. The first medical school paper was
submitted for publication November 30, 2008. This web page and the
links to the right are an overview of the NeuroResearch Clinics
treatment approach of depression in adults and children.
Other pages of this web site discuss the details of the NeuroResearch
Clinics approach in treatment of numerous other neurotransmitter
diseases. (To access the a copy of
the first University of Minnesota Medical School paper click on the
"NeuroResearch Publishing" link in the left column.) |
|
|
|
|
To be
concise, the reuptake inhibitor drugs used
to treat depression, anxiety, attention
deficit ADD ADHD, etc. are not very
effect, deplete neurotransmitters, and are
habit forming. On this page and the links
below it, on the site map to the right, is an in
depth discussion of how and why these drugs
are not very effective, deplete, and
habituate. |
|
The
number one category of drugs used to treat
depression, anxiety, attention deficit ADD
ADHD, etc. in medicine are the
reuptake inhibitors. Make no mistake,
the following things are true: |
|
The reuptake inhibitor
drugs deplete
serotonin, dopamine, and
norepinephrine neurotransmitters
levels in the brain
making the cause of the
disease, low
neurotransmitter levels, worse.
When these drugs deplete
neurotransmitter levels
low enough the drug
quits working and
symptoms of disease
return. In severe cases
of neurotransmitter
depletion people become
suicidal and commit
suicide. The "NT
depletion" link to the
right is an in-depth
discussion on how these
drugs deplete
neurotransmitter levels
and what can be done to
prevent this. |
|
|
The reuptake inhibitor
drugs are not very
effective in
treating depression.
Major medical studies
since 2003 confirm that
in general less than 1
in 10 people taking
these drugs for
depression experience
relief of symptoms
greater than obtained
with taking a
sugar pill (placebo).
The "drug effectiveness"
link to the right
discussed how the real
effectiveness of these
drugs based on
scientific studies. |
|
|
The reuptake inhibitor
drugs are habit
forming to the point
that that people have
difficulty stopping
these drug. The "habit
forming" link to the
right discusses why
these drugs are habit
forming and what can be
done to address this
problem. |
|
|
|
On this
page and the links to the right lead to an
in depth discussion of the effectiveness,
neurotransmitter depletion abilities,
and the habit forming nature of the
reuptake inhibitor drugs used in
medicine to
treat attention deficit ADD ADHD and depression. |
|
|
DOING IT
RIGHT |
|
Under the NeuroResearch Clinics approach to
depression since 2004 100% of people suffering from
depression have found relief of depression symptoms
without using prescription depression drugs. This does not mean
that the drugs should not be used to treat
depression. In extreme depression such as the
suicidal ideation, the catatonic person, or the
person who can't function on a day to day basis the
recommendation is use both a drug and the 5-HTP,
tyrosine, and dopa balanced nutrient formulas developed by NeuroResearch
Clinics. |
|
The links on the right lead to real
life case studies submitted by doctors to
NeuroResearch clinics discussing the
effectiveness of the NeuroResearch
Clinics approach. |
|
|
|
|
Contrary to some of the urban legend unsupported
claims on the internet our experience shows that
these reuptake inhibitor drugs and nutrients such as
5-HTP, tyrosine, and dopa can be safely used at the
same time by all people. To prevent depletion of
neurotransmitter levels by the reuptake inhibitor
drugs during treatment of depression, anxiety,
attention deficit ADD ADHD, etc. proper levels of
the balanced nutrients all people taking them. If
this is done the people will not become habituated
to these drugs and the drugs will not burn out the
serotonin, dopamine, or norepinephrine
neurotransmitter levels. The best of all worlds is
found in treating depression, anxiety, attention
deficit ADD ADHD, etc. with the properly balanced
nutrients 5-HTP, tyrosine, and dopa. The
NeuroResearch Clinics protocol for depression,
anxiety, attention deficit ADD ADHD, etc. when
followed properly gives 100% relief of symptoms of depression
including bipolar depression, without the
prescription drug side effects and without depleting
serotonin, dopamine, or norepinephrine
neurotransmitter levels further. |
|
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
|
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
Depression Pages Site Map |
|
|
|
|
|
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
| |
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
DSM IV
diagnostic criteria for depression |
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
| |
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
If proper levels
of balanced 5-HTP, tyrosine, and
dopa are not given: |
|
5-HTP depletes
dopamine |
|
dopa depletes
serotonin |
|
tyrosine Depletes
serotonin |
|
Reuptake
Inhibitor Drugs deplete serotonin and/or dopamine |
|
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
serotonin reuptake inhibitor norepinephrine reuptake
inhibitor |
|
|
| |
| |
| |
|
|
| |
|
|
| |
| |
|
depression suicide attention
deficit ADD ADHD |
 |
|
|
|
Depression
By: Clarence Graff,
MD |
|
|
|
A person presented wanting a renewal of her Paxil.
She told me she had been on Paxil for some years and
just wanted it renewed. I asked if the drug was
working. She replied no, but it was better than not
taking the drug. On further questioning, she stated
that she had been depressed for several years. She
did not leave the house except in exceptional times
such as drug renewal. She did not go out to buy
groceries and she had not been out socially for
years as she became very anxious out in public. |
|
My opinion was that she had suffered from a reuptake
inhibitor depression drug
failure for the treatment of her depression and
anxiety. After some discussion, it was decided that
she would start a trial of NeuroResearch Clinics balanced
5-HTP,
tyrosine, and dopa
while continuing her Paxil with the goal of
discontinuing the Paxil. Over the course of two
months the Paxil was slowly withdrawn. |
|
Her depression has improved remarkably. She
attended her daughter's wedding and sang a solo.
This would have been impossible with only the Paxil.
Her depression continues
to do extremely well on a maintenance dose of
balanced
5-HTP,
tyrosine, and dopa. |
|
DISCUSSION:
Drugs that work with serotonin and dopamine neurotransmitter
molecules do not work
if there are not enough serotonin and dopamine neurotransmitter
molecules in the
CNS. Reuptake inhibitor
depression / attention deficit ADD ADHD drugs do not increase the number
of serotonin and dopamine neurotransmitter molecules in the brain (CNS),
they work by moving serotonin and dopamine neurotransmitter
molecules from one place
to another. Use of reuptake inhibitor
depression / attention deficit ADD ADHD drugs without
providing adequate
5-HTP,
tyrosine, and dopa precursors will lead
to depletion of serotonin and dopamine neurotransmitter levels
leading to an environment
where prescription
depression / attention deficit ADD ADHD drugs are ineffective.
|
|
First, do no harm. The recommendation is, “if the
person needs to be on reuptake inhibitor depression
/ attention deficit ADD ADHD drugs, they
should be given in conjunction with properly
balanced
5-HTP,
tyrosine, and dopa to prevent
serotonin and dopamine neurotransmitter
depletion by the depression / attention deficit ADD
ADHD prescription drugs.” |
|
When a person is taking reuptake inhibitor
depression / attention deficit ADD ADHD drugs and
they quit working, there is clinical evidence that
the reuptake inhibitor
depression / attention deficit ADD ADHD drugs have depleted the
serotonin and dopamine neurotransmitter
molecules to the point that the
depression / attention deficit ADD ADHD drug no
longer works. The problem is the treatment (using
only
depression / attention deficit ADD ADHD prescription drugs) has just made the cause of
the problem worse, low serotonin and dopamine neurotransmitter levels. |
|
|
|
|
|
 |
| |
| |
| |
|
suicide depression attention
deficit ADD ADHD |
 |
|
|
|
Depression
By: Curt Ficenec, DC |
|
|
|
On a Thursday, late in the day, a new
person
showed in my office. And like all good new people do, the more
complicated, the later in the day they show up, just before closing
time. Anyhow, my person showed up with severe depression. She
had been in and out of mental institutions locally where she was treated
for depression and on all the
reuptake inhibitor
depression / attention deficit ADD ADHD drugs. Nothing seemed to help her and she had tried to
commit suicide on 4 different occasions due to serotonin and dopamine
neurotransmitter levels not being high enough. She had the scars to prove
it. We did a complete history and decided to start the person on
level 1 of the NeuroResearch Clinics protocol of 5-HTP or 5 HTP
with tyrosine. I just had a good feeling about the upcoming
results. |
|
Well, on Friday, she called me.
I was kind of waiting, really expecting to hear that she had not felt
good and had been hospitalized again for depression. I actually began to tell her that it would take
some time to see results as the serotonin and dopamine neurotransmitter
levels increased, when she stopped me and said that her depression felt
better within minutes of taking the NeuroResearch Clinics 5-HTP
or 5 HTP with tyrosine. She said that within an
hour she was calmed and resting a marked improvement in her depression. |
|
Here was a girl that was suffering
depression and on the verge of suicidal
death. She was on disability due to depression. A burden to
society financially and convinced by her doctors that she would be that
way with depression the rest of her life. I would be suicidal
too! |
|
Within one month she not only was
depression gone she almost back to a
normal life, she went out and got a job! She and her entire family
were excited. 8 little pills a day...she takes them on a regular
basis, although cut back to 4 pills a day
now. The serotonin and dopamine approach of NeuroResearch, it works! |
|
|
|
|
|
 |
| |
| |
| |
| |
|
attention deficit ADD ADHD suicide depression |
 |
|
|
|
Depression Fibromyalgia: Peggy Rollo, ND |
|
|
|
A 66 year old female
came in complaining of fibromyalgia like symptoms of
joint pain, fatigue, daily headaches, depression, lack
of motivation, digestive difficulties. She also has
asthma, allergies, weight gain, increased appetite,
repeated colds and bronchitis, sugar cravings, and
chronic vaginitis. She was taking 38 nutritional
supplements daily just to maintain and doesn’t feel
well. If she discontinues her supplements, she feels
worse, especially her energy and digestion. |
|
The person started
on Level 1 dosing of the D5 and CysReplete protocol. At
her follow-up in 7 days, she reported increased energy
for the past 3 days, 2 ˝ pounds weight loss, and filling
up faster when eating. She decreased her vitamin C, and
her allergies got no worse and nasal congestion is
decreased. |
|
The person
increased to Level 2 by adding four D5 extra. At her
14-day day follow-up, her energy was better to the point
that she is no longer exhausted in the evenings. Her
focus has improved, and she has had only one headache
versus daily headaches. She is able to avoid sugar and
not crave it. She reports that her digestion is good.
The person says she is 40% better and feels she needs a
higher dose of
5-HTP,
tyrosine, and dopa. She is tracking more
clearly. |
|
The person
increased to Level 3 by adding another 4 D5 Extra. The
next day, her sinus symptoms and allergies are gone. At
the 21 day follow-up, she has had only 1 headache.
Digestion was good. She had lost 4 pounds at this
point. |
|
Two weeks later, her
mood is up and down. She stopped all her digestive
supplements without repercussions, but would like mood
and energy to be better. |
|
The person
serotonin and dopamine urinary neurotransmitter testing
performed. Subsequently, her
5-HTP, tyrosine, and
dopa dose was increased to Level 4 plus 3
Mucuna 40%. After 7 days, her weight dropped again,
energy was better, depression gone, pain decreased, digestion was normal,
and has had no headaches. |
|
Two weeks later,
this person was in a motor vehicle accident, injured
her knee and was fired from her job. She started
getting late on
5-HTP,
tyrosine, and dopa doses and now her energy is
lower, especially when the Mucuna dose is missed. She
returned to timely doses and was better in 3 days. She
has lost 10 pounds in 5 months versus losing the gradual
weight gain she has had over the past year. |
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |